4//SEC Filing
Ferrara Robert L 4
Accession 0001209191-21-017572
CIK 0001533040other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:05 PM ET
Size
6.6 KB
Accession
0001209191-21-017572
Insider Transaction Report
Form 4
Ferrara Robert L
Director
Transactions
- Award
Common stock, $0.0001 par value
2021-03-01+10,000→ 12,318 total - Purchase
Common stock, $0.0001 par value
2021-03-03$3.15/sh+682$2,148→ 13,000 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- [F2]Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001792987
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:05 PM ET
- Size
- 6.6 KB